USA - New York Stock Exchange - NYSE:BFLY - US1241551027 - Common Stock
The current stock price of BFLY is 2.65 USD. In the past month the price increased by 18.83%. In the past year, price decreased by -18.21%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.67 | 222.97B | ||
| ISRG | INTUITIVE SURGICAL INC | 65.23 | 201.33B | ||
| BSX | BOSTON SCIENTIFIC CORP | 32.84 | 143.55B | ||
| SYK | STRYKER CORP | 27.96 | 140.79B | ||
| IDXX | IDEXX LABORATORIES INC | 57.57 | 58.07B | ||
| BDX | BECTON DICKINSON AND CO | 13.36 | 55.24B | ||
| EW | EDWARDS LIFESCIENCES CORP | 33.12 | 49.40B | ||
| RMD | RESMED INC | 25.33 | 36.59B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.66 | 34.82B | ||
| DXCM | DEXCOM INC | 32.38 | 23.62B | ||
| PODD | INSULET CORP | 72.47 | 23.30B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.39 | 18.26B |
Butterfly Network, Inc. designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment. The company is headquartered in Burlington, Massachusetts and currently employs 190 full-time employees. The company went IPO on 2020-05-26. The firm's solution, leveraging its Ultrasound-on-Chip technology, enables the practical application of ultrasound information into the clinical workflow. Its product portfolio includes a combination of hardware and software, including Butterfly iQ3, Butterfly iQ+, Butterfly iQ+ Bladder, and Butterfly iQ+ Vet devices, software subscriptions, and professional services. The company offers cloud-based software solutions to healthcare systems, teleguidance, in-app educational tutorials as well as its ScanLab education-only app, formal education programs through its Butterfly Academy software and Butterfly Certified courses, as well as professional services for large scale deployments. Its devices are commercially available to trained healthcare practitioners in areas including, but not limited to, parts of Africa, Asia, and Australia.
BUTTERFLY NETWORK INC
1600 District Avenue
Burlington MASSACHUSETTS 06437 US
CEO: Todd Fruchterman
Employees: 190
Phone: 17815574800
Butterfly Network, Inc. designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment. The company is headquartered in Burlington, Massachusetts and currently employs 190 full-time employees. The company went IPO on 2020-05-26. The firm's solution, leveraging its Ultrasound-on-Chip technology, enables the practical application of ultrasound information into the clinical workflow. Its product portfolio includes a combination of hardware and software, including Butterfly iQ3, Butterfly iQ+, Butterfly iQ+ Bladder, and Butterfly iQ+ Vet devices, software subscriptions, and professional services. The company offers cloud-based software solutions to healthcare systems, teleguidance, in-app educational tutorials as well as its ScanLab education-only app, formal education programs through its Butterfly Academy software and Butterfly Certified courses, as well as professional services for large scale deployments. Its devices are commercially available to trained healthcare practitioners in areas including, but not limited to, parts of Africa, Asia, and Australia.
The current stock price of BFLY is 2.65 USD. The price increased by 14.22% in the last trading session.
BFLY does not pay a dividend.
BFLY has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
BUTTERFLY NETWORK INC (BFLY) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
BUTTERFLY NETWORK INC (BFLY) currently has 190 employees.
You can find the ownership structure of BUTTERFLY NETWORK INC (BFLY) on the Ownership tab.
ChartMill assigns a technical rating of 8 / 10 to BFLY. When comparing the yearly performance of all stocks, BFLY is one of the better performing stocks in the market, outperforming 90.29% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to BFLY. No worries on liquidiy or solvency for BFLY as it has an excellent financial health rating, but there are worries on the profitability.
Over the last trailing twelve months BFLY reported a non-GAAP Earnings per Share(EPS) of -0.33. The EPS increased by 28.26% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -27.54% | ||
| ROE | -39.19% | ||
| Debt/Equity | 0 |
10 analysts have analysed BFLY and the average price target is 3.65 USD. This implies a price increase of 37.92% is expected in the next year compared to the current price of 2.65.
For the next year, analysts expect an EPS growth of 23.76% and a revenue growth 12.13% for BFLY